181 related articles for article (PubMed ID: 28705794)
1. Targeted Disruption of JCAD (Junctional Protein Associated With Coronary Artery Disease)/KIAA1462, a Coronary Artery Disease-Associated Gene Product, Inhibits Angiogenic Processes In Vitro and In Vivo.
Hara T; Monguchi T; Iwamoto N; Akashi M; Mori K; Oshita T; Okano M; Toh R; Irino Y; Shinohara M; Yamashita Y; Shioi G; Furuse M; Ishida T; Hirata KI
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1667-1673. PubMed ID: 28705794
[TBL] [Abstract][Full Text] [Related]
2. JCAD, a Gene at the 10p11 Coronary Artery Disease Locus, Regulates Hippo Signaling in Endothelial Cells.
Jones PD; Kaiser MA; Ghaderi Najafabadi M; Koplev S; Zhao Y; Douglas G; Kyriakou T; Andrews S; Rajmohan R; Watkins H; Channon KM; Ye S; Yang X; Björkegren JLM; Samani NJ; Webb TR
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1711-1722. PubMed ID: 29794114
[TBL] [Abstract][Full Text] [Related]
3. A coronary artery disease-associated gene product, JCAD/KIAA1462, is a novel component of endothelial cell-cell junctions.
Akashi M; Higashi T; Masuda S; Komori T; Furuse M
Biochem Biophys Res Commun; 2011 Sep; 413(2):224-9. PubMed ID: 21884682
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.
Liao Z; Cantor JM
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2163-2166. PubMed ID: 27687603
[TBL] [Abstract][Full Text] [Related]
5. The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis.
Xu S; Xu Y; Liu P; Zhang S; Liu H; Slavin S; Kumar S; Koroleva M; Luo J; Wu X; Rahman A; Pelisek J; Jo H; Si S; Miller CL; Jin ZG
Eur Heart J; 2019 Aug; 40(29):2398-2408. PubMed ID: 31539914
[TBL] [Abstract][Full Text] [Related]
6. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
7. A key role for the novel coronary artery disease gene JCAD in atherosclerosis via shear stress mechanotransduction.
Douglas G; Mehta V; Al Haj Zen A; Akoumianakis I; Goel A; Rashbrook VS; Trelfa L; Donovan L; Drydale E; Chuaiphichai S; Antoniades C; Watkins H; Kyriakou T; Tzima E; Channon KM
Cardiovasc Res; 2020 Sep; 116(11):1863-1874. PubMed ID: 31584065
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of Dual-Specificity Protein Phosphatases in Angiogenesis.
Amand M; Erpicum C; Gilles C; Noël A; Rahmouni S
Methods Mol Biol; 2016; 1447():331-49. PubMed ID: 27514814
[TBL] [Abstract][Full Text] [Related]
9. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
10. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
11. PKN3 is the major regulator of angiogenesis and tumor metastasis in mice.
Mukai H; Muramatsu A; Mashud R; Kubouchi K; Tsujimoto S; Hongu T; Kanaho Y; Tsubaki M; Nishida S; Shioi G; Danno S; Mehruba M; Satoh R; Sugiura R
Sci Rep; 2016 Jan; 6():18979. PubMed ID: 26742562
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo.
Ishida T; Kundu RK; Yang E; Hirata K; Ho YD; Quertermous T
J Biol Chem; 2003 Sep; 278(36):34598-604. PubMed ID: 12819200
[TBL] [Abstract][Full Text] [Related]
13. G-protein-coupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation.
Majumder S; Sowden MP; Gerber SA; Thomas T; Christie CK; Mohan A; Yin G; Lord EM; Berk BC; Pang J
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):419-26. PubMed ID: 24265417
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
[TBL] [Abstract][Full Text] [Related]
15. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL
PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth.
Michalik KM; You X; Manavski Y; Doddaballapur A; Zörnig M; Braun T; John D; Ponomareva Y; Chen W; Uchida S; Boon RA; Dimmeler S
Circ Res; 2014 Apr; 114(9):1389-97. PubMed ID: 24602777
[TBL] [Abstract][Full Text] [Related]
17. FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
Yakkundi A; Bennett R; Hernández-Negrete I; Delalande JM; Hanna M; Lyubomska O; Arthur K; Short A; McKeen H; Nelson L; McCrudden CM; McNally R; McClements L; McCarthy HO; Burns AJ; Bicknell R; Kissenpfennig A; Robson T
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):845-54. PubMed ID: 25767277
[TBL] [Abstract][Full Text] [Related]
18. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
19. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
[TBL] [Abstract][Full Text] [Related]
20. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Rybinski K; Imtiyaz HZ; Mittica B; Drozdowski B; Fulmer J; Furuuchi K; Fernando S; Henry M; Chao Q; Kline B; Albone E; Wustner J; Lin J; Nicolaides NC; Grasso L; Zhou Y
Oncotarget; 2015 Sep; 6(28):25429-40. PubMed ID: 26327620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
